ArticleAnnals of medicine and surgery (2012)2026
Burden of lower extremity peripheral arterial disease in the Western Pacific region, 1990-2021: a comparative analysis.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lower extremity peripheral arterial disease (PAD) significantly impairs limb function, yet research is limited. This study utilized data from the Global Burden of Disease (GBD) study to analyze the epidemiological trends of PAD in the Western Pacific region. Methods: This study analyzed PAD burden among individuals aged ≥40 in four representative countries during 1990-2021, using the GBD 2021 dataset, including prevalence, incidence, and disability-adjusted life years (DALYs). The sociodemographic index (SDI) was used to quantify developmental status. Joinpoint regression analysis was employed to assess temporal trends. The Bayesian age-period-cohort model was utilized to predict incidence through 2041. Results: In 2021, the Philippines had the highest incidence, prevalence, and DALY rates, followed by China and Japan. The affected population in the Philippines was younger than in other countries, indicating a uniquely severe burden. China had the highest number of new cases, with 2 447 372 in 2021. Women had a higher disease burden. Incidence, prevalence, and DALY rates all peaked in older age groups. From 1990 to 2021, the PAD burden in China and the Philippines showed an upward trend, whereas that in Japan and South Korea showed a downward trend. Future projections indicate that China will experience an increase in disease burden. Conclusion: PAD imposes a substantial burden in the Western Pacific region. Middle-SDI regions should address its socioeconomic impacts and strengthen prevention strategies, while high-SDI regions should focus on disease control in the elderly. PAD serves as an indicator of arterial health. Preventing PAD may block more fatal cardiovascular events.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.